Biotest AG (BIESF)
Biotest Statistics
Share Statistics
Biotest has 50.97M shares outstanding. The number of shares has increased by -4.46% in one year.
| Shares Outstanding | 50.97M |
| Shares Change (YoY) | -4.46% |
| Shares Change (QoQ) | -5.06% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 20.35M |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | < 0.01% |
Short Selling Information
| Short Interest | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Valuation Ratios
The PE ratio is 41.48 and the forward PE ratio is null. Biotest's PEG ratio is -0.53.
| PE Ratio | 41.48 |
| Forward PE | n/a |
| PS Ratio | 1.51 |
| Forward PS | n/a |
| PB Ratio | 2.06 |
| P/FCF Ratio | 34.01 |
| PEG Ratio | -0.53 |
Enterprise Valuation
Biotest has an Enterprise Value (EV) of 1.58B.
| EV / Sales | 2.18 |
| EV / EBITDA | 13.16 |
| EV / EBIT | 26.02 |
| EV / FCF | 49.2 |
Financial Position
The company has a current ratio of 5.06, with a Debt / Equity ratio of 1.13.
| Current Ratio | 5.06 |
| Quick Ratio | 2.06 |
| Debt / Equity | 1.13 |
| Debt / EBITDA | 4.96 |
| Debt / FCF | 18.55 |
| Interest Coverage | 2.84 |
Financial Efficiency
Return on Equity is 4.97% and Return on Invested Capital is 4.18%.
| Return on Equity | 4.97% |
| Return on Assets | 1.84% |
| Return on Invested Capital | 4.18% |
| Revenue Per Employee | $291.06K |
| Profits Per Employee | $10.58K |
| Employee Count | 2,495 |
| Asset Turnover | 0.51 |
| Inventory Turnover | 1.05 |
Taxes
| Income Tax | 20.2M |
| Effective Tax Rate | 43.44% |
Stock Price Statistics
The stock price has increased by 4.99% in the last 52 weeks. The beta is 0.15, so Biotest's price volatility has been higher than the market average.
| Beta | 0.15 |
| 52-Week Price Change | 4.99% |
| 50-Day Moving Average | 31.64 |
| 200-Day Moving Average | 30.77 |
| Relative Strength Index (RSI) | 100 |
| Average Volume (20 Days) | 1 |
Income Statement
In the last 12 months, Biotest had revenue of 726.2M and earned 26.4M in profits. Earnings per share was 0.71.
| Revenue | 726.2M |
| Gross Profit | 223.8M |
| Operating Income | 94.5M |
| Net Income | 26.4M |
| EBITDA | 120.4M |
| EBIT | 79.8M |
| Earnings Per Share (EPS) | 0.71 |
Balance Sheet
The company has 107.8M in cash and 597.2M in debt, giving a net cash position of -489.4M.
| Cash & Cash Equivalents | 107.8M |
| Total Debt | 597.2M |
| Net Cash | -489.4M |
| Retained Earnings | 274.5M |
| Total Assets | 1.43B |
| Working Capital | 649.4M |
Cash Flow
In the last 12 months, operating cash flow was 60.9M and capital expenditures -28.7M, giving a free cash flow of 32.2M.
| Operating Cash Flow | 60.9M |
| Capital Expenditures | -28.7M |
| Free Cash Flow | 32.2M |
| FCF Per Share | 0.87 |
Margins
Gross margin is 30.82%, with operating and profit margins of 13.01% and 3.64%.
| Gross Margin | 30.82% |
| Operating Margin | 13.01% |
| Pretax Margin | 6.4% |
| Profit Margin | 3.64% |
| EBITDA Margin | 16.58% |
| EBIT Margin | 13.01% |
| FCF Margin | 4.43% |
Dividends & Yields
BIESF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | 2.41% |
| FCF Yield | 2.94% |
Analyst Forecast
Currently there are no analyst rating for BIESF.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Stock Splits
The last stock split was on Nov 2, 2015. It was a forward split with a ratio of 3:1.
| Last Split Date | Nov 2, 2015 |
| Split Type | forward |
| Split Ratio | 3:1 |
Scores
| Altman Z-Score | 2.58 |
| Piotroski F-Score | 6 |